Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2

DSpace Repository

Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2

Author: Reitmajer, Markus; Nanz, Lena; Mueller, Nina; Leiter, Ulrike; Amaral, Teresa; Aebischer, Valentin; Flatz, Lukas; Forschner, Andrea
Tübinger Autor(en):
Reitmajer, Markus
Nanz, Lena
Amaral, Teresa
Aebischer, Valentin
Flatz, Lukas
Müller, Nina
Leiter-Stöppke, Ulrike
Forschner, Andrea Lydia
Published in: Therapeutic Advances in Medical Oncology (2025), Bd. 17, Article 17588359251324035
Verlagsangabe: London : Sage Publications Ltd
Language: English
Full text: http://dx.doi.org/10.1177/17588359251324035
ISSN: 1758-8340
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)